Abstract
Retroviruses are widely distributed in avian and mammalian species, and cause various neoplastic diseases in their natural hosts (1). The type-C retroviruses have been divided into two groups: the replication-competent viruses that induce leukemia in susceptible animals with a long latent period, but do not usually transform cells in culture; and the acute replication-defective viruses that cause leukemias or sarcomas in animals within a few days or weeks and transform cells in vitro. The replication defect of acutely transforming retroviruses is due to the loss of structural genes that are essential for replication with the concomitant acquisition of altered cellular sequences, named oncogenes, responsible for cell transformation. As a result of their replication defectiveness, acutely transforming retroviruses require a helper replication-competent virus for propagation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Reddy EP, Salka AM, Curran T (eds). The Oncogene Handbook. New York: Elsevier; 1988.
Wendling F, Varlet P, Charon M, Tambourin P. MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology. 1986; 149: 242–246.
Troxler DH, Scolnick EM. Rapid leukemia induced by cloned Friend strain of replicating mu rine type-C virus. Association with induction of xenotropic-related RNA sequences contained in spleen focus-forming virus. Virology. 1978; 85: 17–27.
Ruscetti S, Davis L, Field J, Oliff A. Friend murine leukemia virus-induced leukemia is associ ated with the formation of mink cell focus-inducing viruses and is blocked in mice expressing endogenous mink cell focus-inducing xenotropic viral envelope genes. J Exp Med. 1981; 154: 907–920.
Shibuya T, Mak TW. Host control of susceptibility to erythroleukemia and to the types of leukemia induced by Friend murine leukemia virus: Initial and late stages. Cell. 1982; 31: 483–493.
Wendling F, Fichelson S, Heard JM, Gisselbrecht S, Varet B, Tambourin P. Induction of my eloid leukemias in mice by biologically cloned ecotropic F-MuLV. In: Scolnick EM, Levine AJ (eds). Tumor Viruses and Differentiation. New York: Liss; 1983: 357–362.
Wendling F, Penciolelli JF, Charon M, Tambourin P. Factor-independent erythropoietic progenitor cells in leukemia induced by the myeloproliferative leukemia virus. Blood. 1989; 73: 1161–1167.
Wendling F, Vigon I, Souyri M, Tambourin P. Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without addition of growth factors. Leukemia. 1989; 3: 475–480.
Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host range. Proc Natl Acad Sci USA. 1988; 85: 6460–6464.
Souyri M, Vigon I, Penciolelli JF, Heard JM, Tambourin P, Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes he matopoietic progenitors. Cell. 1990; 63: 1137–1147.
Fichelson S, Vigon I, Dusanter I, et al. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.J Immunol. 1995; 154: 1577–1586.
Penciolleli JF, Wendling F, Robert-Lezenes J, Barque JP, Tambourin P, Gisselbrecht S. Genetic analysis of myeloproliferative leukemia virus, a novel acute leukemogenic replication-defective retrovirus. J Virol. 1987; 61: 579–583.
Bishop JM. Cellular oncogenes and retroviruses. Annu Rev Biochem. 1983; 52: 301–354.
Cosman D, Lyman SD, Idzerda RL, et al. A new cytokine receptor superfamily. Trends Biochem Sci. 1990; 15: 265–270.
Bazan JF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA. 1990; 87: 6934–6938.
Bénit L, Charon M, Cocault L, Wendling F, Gisselbrecht S. The ‘WS motif’ common to v-mpl and members of the cytokine receptor superfamily is dispensable for myeloproliferative leuke mia virus pathogenicity. Oncogene. 1993; 8: 787–790.
Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995; 64: 621–651.
Pallard C, Gouilleux F, Bénit L, et al. Thrombopoietin activates a STAT5-like factor in hemato poietic cells. EMBO J. 1995; 14: 2847–2856.
Bénit L, Courtois G, Charon M, Varlet P, Dusanter-Fourt I, Gisselbrecht S. Characterization of mpl cytoplasmic domain sequences required for myeloproliferative leukemia virus pathogenic ity. J Virol. 1994; 68: 5270–5274.
Fukunaga R, Ishizaka-Ikeda E, Pan CX, Seto Y, Nagata S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 1991; 10: 2855–2865.
Murakami M, Narazaki M, Hibi M, et al. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA. 1991; 88: 11, 349–11, 353.
Ziegler SF, Bird TA, Morella KK, Mosley B, Gearing DP, Baumann H. Distinct regions of the human granulocyte-colony-stimulating factor receptor cytoplasmic domain are required for proliferation and gene induction. Mol Cell Biol. 1993; 13: 2384–2390.
Courtois G, Bénit L, MikaeloffY, et al. Constitutive activation of a variant of the env-mpl oncogene product by disulfide-linked homodimerization. J Virol. 1995; 69: 2794–2800.
Watowich SS, Yoshimura A, Longmore GD, Hilton DJ, Yoshimura Y, Lodish HE Homodimer ization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA. 1992; 89: 2140–2144.
Vigon I, Mornon JP, Cocault L, et al. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA. 1992; 89: 5640–5644.
Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA. 1990; 87: 9655–9659.
Gearing DP, Thut CJ, Vantden Bos T, et al. Leukemia inhibitory factor receptor is stucturally related to the IL-6 signal transducer, gpl30. EMBO J. 1991; 10: 2839–2848.
Skoda RC, Seidin DC, Chiang MK, Peichel CL, Vogt TF, Leder P. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBO J. 1993; 12: 2645–2653.
Vigon I, Florindo C, Fichelson S, et al. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene. 1993; 8: 2607–2615.
Mignotte V, Vigon I, Boucher de Crèvecoeur E, Roméo PH, Lemarchandel V, Chrétien S. Struc ture and transcription of the human c-mpl gene (MPL). Genomics. 1994; 20: 5–12.
Alexander WS, Dunn AR. Structure and transcription of the genomic locus encoding murine c-Mpl, a receptor for thrombopoietin. Oncogene. 1995; 10: 795–803.
Jackson IJ. A reappraisal of non-consensus mRNA splice sites. Nucleic Acids Res. 1991; 19: 3795–3798.
Hornkohl A, Selesi B, Bennett L, Hockman H, Nichol J, Hunt P. Thrombopoietin and SMPL concentrations in the serum and plasma of normal donors. Blood. 1995; 86: 838a (abstract no 3580).
Lofton-Day C, Buddle M, Berry J, Lok S. Differential binding of murine thrombopoietin to two isoforms of murine c-mpl. Blood. 1995; 86: 594a (abstract no 2362).
Romeo PH, Prandini MH, Joulin V, et al. Megakaryocytic and erythrocytic lineages share spe cific transcription factors. Nature. 1990; 344: 447–449.
Martin DI, Zon LI, Mutter G, Orkin SH. Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages. Nature. 1990; 344: 444–447.
Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Roméo PH. GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol. 1993; 13: 668–676.
Le Coniat M, Souyri M, Vigon I, Wendling F, Tambourin P, Berger R. The human homolog of the myeloproliferative virus maps to chromosome band lp34. Hum Genet. 1989; 83: 194–196.
Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell. 1985; 41: 665–676.
Besmer P, Murphy JE, George PC, et al. A new acute transforming feline retrovirus and rela tionship of its oncogene v-kit with the protein kinase gene family. Nature. 1986; 320: 415–421.
Downward J, Yarden Y, Mayes E, et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature. 1984; 307: 521–527.
Watowich SS, Yoshimura A, Longmore GD, Hilton DJ, Yoshimura Y, Lodisch HF. Homodimerization and constitutive activation of the erythropoietin receptor.Proc Natl Acad Sci USA. 1992; 89: 2140–2144.
Alexander WS, Metcalf D, Dunn AR. Point mutations within a dimer interface homology do main of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J. 1995; 14: 5569–5578.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Humana Press Inc.
About this chapter
Cite this chapter
Wendling, F., Gisselbrecht, S. (1997). The Murine Myeloproliferative Leukemia Virus MPLV, v-mpl Oncogene, and c-mpl . In: Kuter, D.J., Hunt, P., Sheridan, W., Zucker-Franklin, D. (eds) Thrombopoiesis and Thrombopoietins. Humana Press. https://doi.org/10.1007/978-1-4612-3958-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3958-1_6
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8440-6
Online ISBN: 978-1-4612-3958-1
eBook Packages: Springer Book Archive